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OSTEOBLASTS (HOS CELLS) STIMULATED WITH HYDROXYAPATITE 
ABSTRACT 
Hydroxyapatite (HA) as a ceramic material is widely used for orthopaedic and 
dental implants, since this biomaterial has ability to stimulate osteoblast functions in 
vitro and in vivo. However, the exact mechanism by which HA accelerates osteoblast 
function, thereby stimulating rapid bone formation, remains far from clear. It is well 
known that bone formation is tightly regulated by nitric oxide (NO) via its effects on 
osteoblast and osteoclast function. Therefore, the overall aim of the present studies was 
to elucidate the possible regulation ofNO in HA-stimulated HOS cell proliferation. The 
present study used a human osteoblast cell line (HOS cells), since this cell line is known 
to mimic the functions of normal human osteoblasts, thereby representing the biological 
response of normal osteoblasts in humans. 
The first experiments were carried out to delineate whether HA-stimulated HOS 
cell proliferation is regulated by endogenous NO. The results showed that following 
contact with HA, elevated NO production and HOS cell proliferation were observed. 
Exogenous L-arginine further promoted HA-stimulated osteoblast NO production and 
proliferation. Furthermore, cell proliferation and NO production by HA-stimulated HOS 
cells in the presence of anti-human integrin a V antibody were reduced. Similarly 
reduction of cell proliferation and NO production by HA-stimulated HOS cells was 
observed when the cells were incubated with eNOS, but not nNOS and iNOS, inhibitor. 
Deletion of NO production by a NO scavenger resulted in suppressed HA-stimulated 
osteoblast proliferation. 
The effect of exogenous NO on HA-stimulated HOS cell proliferation was then 
determined. The results showed that exogenous NO up to 20 !J.M enhances HA-
XV 
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cell proliferation was abolished by the presence of NO scavenger but only partially 
reduced by eNOS inhibitor. The effect of exogenous NO on HA-stimulated HOS cells 
proliferation was also reduced when the cells were pre-treated with anti-human integrin 
aV antibody. 
The next experiments were to determine whether the regulation of NO on HA-
stimulated HOS cell proliferation was via its ability to enhance prostaglandin E2 (PGE2) 
production. The results showed that the production of PGE2 by HA-stimulated HOS 
cells was augmented by exogenous NO. The presence of NO scavenger suppressed the 
production of PGE2 by HA-stimulated HOS cells with or without the presence of 
exogenous NO. The presence of eNOS inhibitor only partially suppressed the 
production of PGE2 by HA-stimulated HOS cells with ·or without the presence of 
exogenous NO. Again, the production of this prostaglandin by HA-stimulated HOS 
cells with or without the presence of NO was reduced when the HOS cells were pre-
treated with anti-human integrin aV antibody. The production of this prostaglandin and 
cell proliferation by HA-stimulated HOS cells with or without the presence of NO was 
reduced when the HOS cells were pre-treated with indomethacin{a COX-1 and COX-2 
inhibitor) or nimesulide (a COX-2 inhibitor) but not aspirin (a COX-1 inhibitor), 
suggesting COX2-mediated PGE2 synthesis. HA-stimulated cell proliferation with or 
without the presence of NO was also decreased, when HOS cells were pre-coated with 
anti-human EP4 receptor antibody. . 
The next experiments were to assess whether the regulatory role of NO on HA-
stimulated HOS cell proliferation involves the cyclic nucleotide [cyclic guanosine 
monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP)] activity. The 
results of the present study showed that HA-stimulated HOS cells with or without the 
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cAMP but not cGMP analog augmented HA-stimulated HOS cell proliferation with or 
without the presence of NO. An adenylyl cyclase but not a guanylyl cyclase inhibitor 
suppressed HA-stimulated HOS cell proliferation with or without the presence of NO. 
In the presence of carboxy PTIO or L-NIO, the levels of cAMP in HA-stimulated HOS 
cells with or without the presence of NO were reduced. However, in the presence of 
carboxy PTIO or L-NIO, both endogenous and exogenous NO in HA-stimulated HOS 
cells were still able to induce the production of cAMP. The presence of anti-integrin aV 
antibody in HA-stimulated HOS cells also reduced the production of cAMP. However, 
---~---- exogenous or-No- wasstillaDleto sliglitlyinc-rease the -Ievels ofcAMPin--tlye-culttrres of---
anti-integrin aV-coated cells incubated on the HA surfaces. HA-stimulated HOS 
proliferation with or without the presence of exogenous NO was enhanced by forskolin, 
an adenylyl cyclase activator, and IBMX, a phosphodiesterase (PDE) inhibitor. The 
proliferation of HA-stimulated HOS cell proliferation with or without the presence of 
exogenous NO was significantly reduced when the cells were pre-treated with KT5720, 
a protein kinase A (PKA) inhibitor. 
In conclusion, the present study showed that upon stimulation with HA, HOS 
cells proliferated and produced NO in an integrin aV molecule and eNOS dependent 
mechanism and that HA-stimulated HOS cell proliferation was regulated by endogenous 
NO in an autocrine fashion. Exogenous NO augmented HA-stimulated HOS cell 
proliferation independent on endogenously synthesized NO but partially dependent on 
the interaction ofHOS cell surface integrin aV molecule and HA. The binding between 
HOS cell surface integrin aV and HA surface increased synthesis of PGE2 via COX-2 
activities. The released PGE2 would then bind on EP4 receptor in an autocrine 
mechanism. In this respect, NO up-regulated the COX-2-mediated PGE2 synthesis. 
xvii 
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pathway which was controlled by PDE activity. Nitric oxide did amplify cAMP activity, 
thereby enhancing the HA-stimulated HOS proliferation. Therefore, the results of the 
present study demonstrate, for the first time, that the role of NO on HA-stimulated HOS 
cell proliferation may be via its ability to up-regulate the production of COX2-mediated 
PGE2 synthesis and the cAMP-PKA pathway. 
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MANUSIA (SEL HOS) YANG DISTIMULASI DENGAN HIDROKSIAPATIT 
ABSTRAK 
Hidroksiapatit (HA), yang merupakan bahan seramik, digunakan dengan meluas 
didalam bidang ortopedik dan implantologi pergigian kerana keupayaannya untuk 
meyebabkan stimulasi fungsi 'in vitro' dan 'in vivo' sel osteoblas. Walaubagaimanapun, 
mekanisma dimana HA menggalakkan fungsi sel osteoblas, iaitu pembentukkan tulang 
masih tidak jelas. Nitrik oksida (NO) meregulasi pembentukkan tulang melalui 
kesannya terhadap fungsi sel osteoblas dan osteoklas. Maka, tujuan keseluruhan kajian 
terkini adalah untuk mengetahui kemungkina:n regulasi NO tethadap proliferasi sel HOS 
yang telah distimulasi oleh HA. Kajian ini telah meggunakan sel induk osteoblas 
manusia (sel HOS) kerana sel-sel ini dapat mewakili respons biologikal sel osteoblas 
normal manusia. 
Eksperimen yang pertama bertujuan untuk mengetahui jika NO endogenus 
memainkan peranan dalam regulasi proliferasi sel HOS yang telah distimulasi oleh HA. 
Keputusan yang diperolehi menunjukkan bahawa dengan pendedahan terhadap HA, 
peningkatan dalam produksi NO dan prolifearsi sel HOS diperhatikan. L-arginin 
eksogenus pula dapat mempromosi produksi NO dan proliferasi sel osteoblas yang telah 
distimulasi oleh HA. Proliferasi sel dan produksi NO oleh sel HOS yang telah 
distimulasi oleh HA turut berkurangan dengan kehadiran antibodi anti-human integrin 
a V. Kesan pengurangan yang sama turut diperhatikan apabila sel-sel itu diinkubasi 
dengan perencat eNOS dan bukan perencat nNOS atau iNOS. Penghapusan produksi 
NO oleh perencat NO telah menyebabkan perencatan proliferasi sel osteoblas yang telah 
distimulasi oleh HA. 
XIX 
oleh HA dikenalpasti. Keputusan yang diperolehi menunjukkan bahawa NO eksogenus, 
sehingga 20J.tM dapat meggalakkan proliferasi sel HOS yang telah distimulasi oleh HA. 
Pengaruh ini terns terhapus sepenuhnya dengan kehadiran perencat NO tetapi 
mengalami separa pengurangan dengan kehadiran perencat eNOS. Pengaruh NO 
eksogenus ini juga turut berkurangan apabila sel-sel itu telah terlebih dahulu didedahkan 
kepada antibodi anti-human integrin aV. 
Eksperimen seterusnya adalah untuk mengenalpasti regulasi NO terhadap 
proliferasi sel HOS yang telah distimulasi oleh HA melalui keupayaannya untuk 
menggalakkan penghasilan prostaglandin E2 (PGE2). Keputusan yang diperolehi 
menunjukkan, produksi PGE2 oleh sel HOS yang telah distimulasi oleh HA adalah 
dipengaruhi oleh NO eksogenus. Kehadiran perencat NO menyebabkan suppresi 
penghasilan PGE2 oleh sel HOS yang telah distimulasi oleh HA, tanpa dipengaruhi oleh 
kehadiran atau ketidakhadiran NO eksogenus. Kehadiran perencat eNOS pula hanya 
menyebabkan suppresi separa penghasilan PGE2. Selain itu, penghasilan prostaglandin 
oleh sel HOS yang telah distimulasi oleh HA dengan atau tanpa kehadiran NO juga 
didapati berkurangan apabila sel HOS dirawat terlebih dahuhi dengan antibodi anti-
human integrin aV. Penghasilan prostaglandin dan proliferasi sel HOS yang telah 
distimulasi oleh HA dengan atau tanpa kehadiran NO didapati berkurangan apabila sel-
sel HOS dirawat terlebih dahulu dengan indomethacin (perencat COX-1 & COX-2) 
ataupun nimesulide (perencat COX-2) tetapi bukan dengan aspirin. Keputusan ini 
mencadangkan sintesis PGE2 dimediasikan oleh COX-2. disamping itu, proliferasi sel 
yang telah distimulasi oleh HA menjadi kurang dengan atau tanpa kehadiran NO apabila 
sel-sel HOS menjalani rawatan terlebih dahulu dengan antibodi anti-human reseptor 
EP4. 
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NO keatas proliferasi sel HOS yang telah distimulasi oleh HA melibatkan aktiviti 
neukleotida siklik [cyclic guanosine monophosphate ( cGMP) and cyclic adenosine 
monophosphate (cAMP)]. Keputusan daripada ujikaji ini telah membuktikan bahawa 
sel-sel HOS yang telah distimulasi oleh HA dengan atau tanpa kehadiran NO 
meregulasikan had cAMP tetapi bukan cGMP. Penambahan analog eksogenus cAMP 
telah meningkatkan lagi proliferasi sel-sel HOS yang telah distimulasi oleh HA dengan 
atau tanpa kehadiran NO. Keadaan ini tidak dapat diperhatikan apabila analog 
eksogenus cAMP ditambahkan. Perencat 'adenyl cyclase' tetapi bukan perencat 'guanyl 
cyclase' dida.pati telah mengurangkan proliferasi sel HOS yang telah distimulasi oleh 
HA dengan atau tanpa kehadiran NO. dalam kehadiran karboksi PTIO atau L-NIO, 
kuantiti cAMP di dalam sel-sel HOS yang telah distimulasi oleh HA dengan atau tanpa 
kehadiran NO juga didapati berkurangan. Walaubagaimanapun, kehadiran karboksi 
PTIO atau L-NIO, kedua-dua endogenus dan eksogenus NO didalam sel-sel HOS yang 
telah distimulasi oleh HA masih berupaya untuk memulakan penghasilan cAMP. 
Penghasilan cAMP juga kelihatan berkurangan dengan kehadiran antibodi anti-human 
integrin aV didalam sel-sel HOS yang telah distimulasi oleh HA. Sementara itu, kuantiti 
cAMP didalam kultur sel-sel yang diselaputi oleh anti-integrin aV dan diinkubasi pada 
permukaan HA, menunjukkan peningkatan kecil dengan kehadiran NO eksogenus. 
Forskolin, sejenis activator siklase adenil dan IBMX, sejenis perencat fosfodiesterase 
meningkatkan proliferasi sel-sel HOS yang telah distimulasi oleh HA dengan atau tanpa 
kehadiran NO eksogenus. Walaubagaimanapun, proliferasi sel-sel tersebut berkurangan 
apabila dirawat dengan KT5720, sejenis perencat protein kinase, sebelum ujikaji. 
Kesimpulannya, kajian ini menunjukkan bahawa sel-sel HOS apabila distimulasi 
oleh HA mengalami proliferasi dan menghasilkan NO didalam molekul integrin aV 
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endogenus dalam bentuk autokrin. NO eksogenus telah menambahkan proliferasi sel-sel 
HOS yang telah distimulasi oleh HA tanpa bergantung sepenuhnya kepada NO 
endogenus yang disintesiskan. Walaubagaimanapun, proliferasi sel-sel tersebut sedikit 
sebanyak kepada interaksi diantara molekul integrin aV pada permukaan sel HOS dan 
HA. Perikatan di antara molekul integrin aV yang terdapat pada permukaan sel-sel HOS 
dengan permukaan HA telah meningkatkan sintesis prostaglandin melalui aktiviti 
COX-2. Prostaglandin yang dihasilkan kemudiannya akan terikat kepada reseptor EP4 
melalui mekanisma autokrin. Dalam konteks ini NO meregulasi sintesis prostaglandin 
yang dipefantarai oleh COX-2. selain itu proliferasi sel-sel HOS yang distimulsai oleh 
HA bergantung kepada laluan cAMP-PKA yang sebenamya dikawal oleh aktiviti PDE. 
Nitrik oksida juga membantu aktivit cAMP dengan menambahkan proliferasi HOS 
yang distimulasi oleh HA. Oleh yang demikian, kajian ini menunjukan untuk yang 
pertama sekali bahawa pengaruh NO keatas proliferasi sel-sel HOS yang distimulasi 
oleh HA mungkin adalah melalui regulasi sintesis prostaglandin yang diperantarai oleh 
COX-2 danjuga laluan cAMP-PKA. 
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CHAPTER! 
INTRODUCTION AND LITERATURE SURVEY 
1 
1.1 HYDROXYAPATITE 
Ceramics used for the repair and reconstruction of diseased or damaged parts of 
human body are termed as bioceramics. In the past two decades, the utilization of 
calcium hydroxyapatite and tricalcium phosphate as fillers, spacers, and bone graft 
substitutes for orthopaedic as \vel! as maxillofacial surgery has recei\ed great attention, 
primarily because of their biocompatibility, bioactivity, and osteoconduction 
characteristics (Damien and Parsons, 1990). Attentions have been particularly placed on 
the fabrication of bioceramics with "porous" configuration allo\Ying the tissue to 
infiltrate, which further enhances the implant-tissue attachment (Ohgushi, et a/.,1992; 
Klein, eta!., 1994; Fabbri, et al., 1994; Fabbri, et al., 1995; Le Huec, eta/., 1995; Liu, 
1996) (see Fig. 1.1) 
Hydroxyapatite (HA) is one of the ceramic materials commercially used for 
orthopaedic and dental implants, since it enhances osteoblast proliferation and 
differentiation, thereby inducing bone formation. How·ever, high degree of brittle and 
low· strength seems to be a major drawback of this material. Hydroxyapatite is the major 
component, and an essential ingredient, of normal bone and teeth. It makes up bone 
mineral and the matrix of teeth and gives rigidity of bones and teeth. It is chemically 
similar to the mineral component of bones and hard tissues in mammals and, hence, is 
one of the frequently used bioceramics for bone and dental tissues reconstitution. It has 
excellent biocompatibility with hard tissues (Wozney and Rosen, 1998; Suchanek and 
Yoshimura, 1998), and high osteoconductivity and bioactivity despite its low 
degradation rate (LeGeros, et a!.,. 1995, Asashina, et a/., 1997; Suchanek and 
Yoshimura. 1998; Ducheyne and Qiu, 1999; Burg, et a!., 2000; Green, et a/., 2002), 
mechanical strength and osteoinductive potential (Asashina, et a!., 1997, Burg, et a!., 
2000; Reddi, 2000). It has neither antigenicity nor cytotoxicity (Burg, eta!., 2000). It is 
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Fig.l.l Scanning electron micrograph of bovine bone-derived hydroxyapatite (A), 
biphasic calcium phosphate (B) and coralline hydroxyapatite (C). (Figure taken 
from LeGeros Z (2002). Clin Orthop Related Res 395:91-98) 
one of few materials that are classed as bioactive, since it supports bone in grovvth and 
osseointegration when used in orthopaedic, dental and maxillofacial applications. The 
chemical nature of hydroxyapatite lends itself to substitution, since it is not uncommon 
for non-stoichiometric hydroxyapatites to exist. The most common substitutions involve 
carbonate, fluoride and chloride substitutions for hydroxyl groups, while defects can 
also exist resulting in deficient hydroxyapatites. 
Hydroxyapatite consists of Ca2+ ions surrounded by both Pol· and Olf ions, 
and has the chemical formula Ca5(0H)(P04)3. It is also known as tricalcium phosphate 
and calcium hydroxyapatite (Sivakumar, 1998) and used for implant fixation in hard 
tissue prosthetics. A thin layer of HA is applied to the surface of a metal substrate, 
which provides the bioactivity of composite. Previous studies on HA-coated implants 
showed good bone fixation due to its good osteogenic response. (Koeneman, et al., 
1990). However, particulate debris at the bone prosthesis interface has been found to 
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cause a foreign response that is destructive to the surrounding tissues. The poor bonding 
strength of HA to the substrate results in loss of fixation of the prosthesis at the metal-
HA interface. In the development of bone substitutes, a high porosity level is required 
for the following considerations. 
1. Porous materials haYe a large surface area to volume ratio, resulting in significant 
bioresorption, \\hich induces high bioactiYity. 
2. Interconnected pores permit tissue ingro\Yth and thus anchor the prosthesis to the 
surroundmg bone, pre\ enting loosening of implants. 
3. Interconnected porosity acts like an organization of \ascular canals that can ensure 
the blood and nutrition supply for the bone. 
1.1.1 Chemically Dedved Synthetic Ceramic 
Hydroxyapatite is Ca 10(P04)r,(OH)2 (Burwell, 1994; Sivakumar, 1998) and a 
stoichiometric compound with a Ca/P mole ratio of 1.(Schimandle, er a!., 1995; 
SiYakumar, 1998). It is formed by precipitation of Calcium nitrate and an1monium 
dihyclrogen phosphate. (Sivakumar, 1998) Hydroxyapatite alone has been found to be 
insufficient lor formation of bone in numerous studies. (Chappard, era!, 1993; Burwell, 
1994: Begley, eta!., 1995; Emery, eta!., 1996; Johnson, eta!., 1996; Rueger, eta!., 
1998; Sandhu and Boden, 1998). 
Rahimi, et al (1997) have used coral based hydroxyapatite as a bone graft 
substitute in foot and ankle surgery with excellent results in an 8-year study. Shahgaldi 
(1998) used coral based hydroxyapatite for restoration of osteochondral defects. Boden 
(1999) found that hydroxyapatite (coral based) mixed with autograft as graft extender 
but nor bone marrow aspirate resulted in postero-lateral fusion of the spine. Passuti, et 
a! (1989) used macroporous, synthetic, hydroxyapatite for adolescent scoliosis for 12 
patients ·with a 24-month follow-up. This study found certain levels of ceramic 
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resorbtion with ne\V bone formation and fusion in all cases. Ransford, et al (1998) in a 
randomized, prospective trial, at centers in UK and France, found no difference between 
auto grafts and synthetic hydroxyapatite (Trio site) in 341 patients of scoliosis. Gouin 
(1995) followed up 19 of 21 patients of bone defects following tumors, non-unions and 
osteotomies, treated with synthetic hydroxyapatite. The ceramic was used alone in 6 
cases, with bone marrow in 12 cases and with autograft in five. All defects healed and 
17 ofthem had a union time ofthree months. Toth (1995) found that the porous calcium 
phosphate ceramics mixed with autogrart in the ratio of 70 (ceramic): 30 (autograft) 
\\'ere eiYectn e for anterior cervical interbody fusion in goat. Itokazu (1996) reported that 
tibial plateau fractures receiYing interporous hydroxyapatite as a bone graft substitute 
united with full function. Bucholz, et a/ (1989) reported that graft \Yith interporous 
hydroxyapatite as bone gran substitute results in similar to that with autografts. 
In an experimental study comparing the various bone graft substitutes, Johnson 
er a/ (19%) found that hydroxyapatite alone gave poor results. Only one out of nine 
defects united. When mixed with bone marro-vv aspirate, it gave results similar to 
autografts, but not as good as autografts. They also noted that presence of 
hydroxyapatite, which is not resorbed, made radiological assessment of union almost 
impossible 
1.1.2 Pt·operties 
Hydroxyapatite is a thermally unstable compound, decomposing at temperature 
from about 800-1200°C depending on its stoichiometry. Generally, dense 
hydroxyapatite does not have the mechanical strength to enable it to succeed in long 
term load bearing applications. Hydroxyapatite coatings are often applied to metallic 
implants (most commonly titanium/titanium alloys and stainless steels) to alter the 
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surface properties and the recipients well accept hydroxyapatite-type materials. On the 
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other hand, HA- uncoated materials would act as a foreign body vvhich, in turn, would 
be isolated from the surrounding tissues. To date, the only commercially accepted 
method of applying hydroxyapatite coatings to metallic implants is plasma spraying. 
Hydroxyapatite may be applied in forms of powders, porous blocks or beads to fill bone 
defects or voids. The bone filler provides a scaffold and induces the rapid filling of the 
void by naturally forming bone. It also becomes part of the bone structure and reduces 
healing times compared to the situation. 
1.2 HYDROXYAPATITE AND OSTEOBLAST 
The surface of implant materials presented to cells can be considered as a 
foreign chemical species with reactive sites. The end groups of polymer chains may also 
interact with reactive groups such as protein or carbohydrate molecules in serum. When 
a material is implanted in vivo, it is immediately covered with a thin layer of 
extracellular fluid, and it is through this layer that the cells interact with the implant 
material (Kasemo and Lausmaa, 1994). The bonding established varies depending on 
the forces, with van der Waals attractions through to covalent bonding (Kasemo and 
Lausmaa, I 994; Takahiro, et a!, 1997). Cells placed in contact with a biomaterial 
surface may show a range of responses from induction of an inflammatory response 
through to perception of the material as 'tissue-like' invoking no reaction. The nature of 
the cellular response determines whether the implant becomes encapsulated with fibrous 
tissue, or initiates bone growth, if indirect contact with bone (Kasemo and Lausmaa, 
1994). There are four possible responses that may occur; tissue death (toxic materials), 
fibrous tissue formation (inert materials), interfacial bond formation (bioactive 
materials), or replacement by surrounding tissue (biodegradable materials) (Hench, 
1988). 
6 
1.2.1 Attachment And Spreading 
Interaction of cells and HA requires specific interaction of adhesion molecules 
and extracellular matrix. limnediately after implantation, implant surfaces are markedly 
changed by the adsorption of proteins and other components from exposure to blood at 
the implant site. Comparing \Yith other implant materials such as titanium, HA has a 
strong adsorptiw property for protein due to the ionic strength and crystallinities of this 
material (Kandori, eta!.. 2005: Yang, eta!., 2005). Indeed, HA adsorbed serum-derived 
fibronectin, Yitronectin and integrin molecules much stronger than titanium (Matsuura, 
era!, 2000: Kilpadi, era!.. 2001), suggesting that HA may have higher affinity than 
other implant materials for extracellular matrix (ECM) adsorption Osteoblasts cultured 
in serum-free medium failed to attach in HA surfaces (Okamoto, et a!., 1998) 
suggesting that serum ECM adsorbed onto HA surface is pre-requisite for osteoblast 
attachment on HA surface. Further studies revealed that RGD peptides are the specific 
ECM site\\ here osteoblasts are attached (Okamoto, eta!., 1998; !vlatsuura, eta!., 2000; 
Itoh, eta! .. 2002). 
Since osteoblasts attach on ECM adsorbed on HA surface, the cells require 
specific protein receptors which bind \Vith ECM. Following osteoblast-HA interaction, 
the expression of osteoblast surface integrin aV and ~V subunits was increased (de 
Ruijter, et al. 2001). Matsuura and colleagues demonstrated that when osteoblasts were 
pre-coated with anti-integrin aV antibody, these cells failed to attach and spread on HA 
surfaces in serum-containing culture medium, suggesting that osteoblast surface integrin 
aV molecules may bind on serum-coated HA surface (Matsuura, et al., 2000). Thus, it 
seems to suggest that interaction of osteoblast integrin aV and RGD peptide of ECM 
may result in the induction of signal transduction which lead to cell attachment and 
spreading on the surface of HA · 
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The surface of HA is highly reactive and can bind strongly with bone (Gruen, 
1979: Posner and Betts, 1975). Cells react to HA presented 'vvithin the material surface 
topography. Topography can be subdivided into macro and micro-topography; \Vith 
macro-topography dealing with the physical configuration of the implant (e.g. screw 
threads), and micro-topography resulting from surface roughness or texture (Mohan, et 
a!, 1999; Curtis <md Riehle, 1999). The material surface can inf1uence cell reaction 
through changes in the cytoskeleton, a network of protein filaments extending through 
the cell cytoplasm \Vithin euk.aryotic cells (Alberts, et a/., 1989; Amos and Amos, 
1991) 
The actin microfilament cytoskeleton is inYolved in the formation of cell 
processes, cell shape, and cell attachment. rviicrospikes,or filopodia, are thin projections 
ofthe plasma membrane supported by actin bundles (Alberts, et al., 1989). As the cell 
adheres to a substrate material, filopodia are formed and moved into place by actin 
acting upon the plasma membrane. The actin is observed in the filopodia as tight 
parallel bundles. Contractile stress fibres are seen once the filopodia are attached 
(Cooper, 1997). Cells use topography for orientation, alignment, and migration by 
recognising surface features and reacting to them, possibly by reshaping their actin 
filaments in filopodia, resulting in contact guidance (see Fig. 1.2). When the 
microspikes find a suitable site, focal adhesions and mature actin fibres are formed. The 
probing of the microspikes can be influenced by surface discontinuities (Clark, et a!., 
1990; Walboomers, eta/., 1999). 
Various biomaterials have been studied as tissue replacements for bony skeletal 
defects originated from trauma, tumor resection and skeletal abnormalities. The 
commonly used bone grafting materials included autografts, allografts, xenografts and 
synthetic composites (Costantino.and Friedman, 1994). Although autografts are most 
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Fig. 1.2 Scanning electron micrograph of human osteoblasts on HA-coated poly cement. 
Cells attached on poly cement shovved a flattened shape (a and b). Cells 
attached on HA-poly cement showed extension of osteoblast filaments which 
adhered on exposed HA surface (c-f). Extended anchorage cells was formed by 
the cells to adhere on HA surface (f) Figure is taken from Dalby MJ, et a! 
(200 l) Biomatertals 22:1739-1 74 7. 
suitable for bone regeneration, they have to be dissected from the other bone tissues of 
the host. It causes donor site morbidity and is usually difficult to form the desired shape. 
On the other hand, allografting and xenografting have the disadvantages of causing 
immune reaction and transferring pathogens. Collagen and hydroxyapatite have been 
used as the bone-filling materials in orthopedic surgery (Bell and Beirne, 1988; Hahn, et 
a/., 1988; Marouf, eta!., 1990). 
The collagen fibers are known to serve as the scaffold for tissue repair 
(Pachence, 1996), whereas hydroxyapatite is well compatible and osteoconductive for 
bone regeneration. While the den?e hydroxyapatite disc is not biodegradable, particulate 
hydroxyapatite can be removed and remodeled in the host (Pohunkova and Adam, 
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1 995). Unfortunately, direct implantation of hydroxyapatite particles resulted in the 
dislocation of material within the tissue. To eliminate the undesired mobility, 
hydroxyapatite powders are often mixed with collagen (Sugaya,. et al., 1989), gelatin 
(Nagase, et a/., 1989) or fibrin glue (Wittkampf, 1988), when used as bone grafts. 
Although most of the collagen matrices are prepared in a slab form, spherical 
composites of collagen and hydroxyapatite are more \'ersatile in biomedical 
applications Other than being used for cell culturing, spherical gel beads ha1·e greater 
flexibility in filling different geometric cavity with closer packing than gels with 
nonspherical shapes. Microspheres composed of collagen and hydroxyapatite are also 
inJectable for repairing tissue defect Collagen gel beads haYe been prepared by 
discharging a suspension of crude collagen fibers into liquid nitrogen (Dean, et a!., 
J9g9). The collagen used in this process contains the amino-terminal telopeptides which 
could induce immune response of the host 
The body produces biological HA for use as a structural component in bone. In 
cortical (compact) bone, HA crystals are found within collagen as needles oriented in 
the direction of the. bers (Kaplan, et a/.,1994, Narasaraju and Phebe, 1996; Shackelford, 
1 999). The needles are nanodimensional, generally 1 0-60nm long and 2-6nm wide 
(Narasaraju and Phebe, 1996), and are bound to collagen fibers (Guyton, 1991 ). 
Synthetic HA has the same chemical composition as biological HA and thus mimics 
many properties of natural bone (Jarcho, 1992). When used to coat an orthopedic or 
dental implant, synthetic HA provides a surface for the anchorage-dependent osteoblasts 
to deposit calcium-containing mineral. This promotes osseointegration of an implant, 
stabilizing it, and preventing motion-induced damage (Jarcho, 1992; Willmann, 1993; 
Cabanela, 1999; Soballe, 1999). HA has been labeled "osteoconductive" due to its 
ability to bind strongly with natu;al bone tissue (Dalby, 2001). Despite these optimal 
properties, synthetic HA is limited in use due to high in vivo solubility and poor 
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mechanical properties, such as low impact resistance (Jarcho, 1992; Willmann, 1993; 
Soballe. 1999). Several researchers have attempted to remedy these problems by doping 
synthetic H.:\ with small amounts of impurities Biologic al HA crystals in vivo also 
contain many impurities, e.g .. substitutions of K+, Mg2+, Na+, co/·, and F, which 
usually reflect dietary history, but can also indicate exposure to environmental hazards, 
eg. Pb2+ <md Sr2+ (Gu)ton, 1991; Kaplan, et.al.,l994; Narasaraju and Phebe, 1996) 
These ionic substitutions can alter properties of HA (such as solubility and mechanical) 
either causmg or inhibiting normal function, e.g .. excessive fluoride can weaken bone 
(Kaplan, e/ a!., 1994; Martin, 1999). 
Webster, et al., (2002) reported that doping HA with 2mol% of Zn2+ 
significantly increased osteoblast adhesion as compared to undoped HA. Furthermore, 
Ito. el a!., (2000), determined that doping with Zn2+ in amounts between 0.6 and 
1.2v.t% enhanced the proliferation of mouse osteoblast-like cells in a tricalcium 
phosphate/I-lA composite ceramic. A similar study also found Zn2+ to be an in vitro 
inhibitor of osteoclastic bone resorption (Ito, et al., 2001). Moreover, doping with 2 
mol% of Mg2+ significantly enhanced osteoblast adhesion as compared to undoped HA. 
However, Serre et a!., (1998), discovered that the addition of 20 wt% Mg2+ 
reduced the osteoconductivity of an apatite sample with osteoblast-like cells, indicating 
that too much substitution exceeded the potential benefits of doping. Webster, et al., 
(2002), also reported that osteoblast adhesion on HA doped \Vith 2 mol% yttrium (Y3+) 
was 28% greater than on undoped HA. This response was greater than osteoblast 
adhesion to other HA formulations in that study, including Zn2+ and Mg2+ as well as 
Cd-doped HA formulations.Greater amounts of added Y3+ achieved greater adhesion 
results, but the effect seemed to level off in the range of 5-7 mol% (Webster, et al., 
2002). 
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Fig. 1.3 Scarming electron micrograph of osteoblasts on HA granule. (A) HA surface 
covered by cells; (B) Cells on the surface of HA; (C) Cells in the pores of 
particle. Figure is taken from Turhani D, era!. (2005). J Oral Maxi!loftic Surg 
63 793-799. 
1.2.2 Proliferation And Differentiation 
In general, following osteoblast attachment on the HA surface, osteointegration 
is inititated by the formation of non-collagen proteins such as osteopontin and bone 
sialoprotein at the surface of material.. Calcium phosphate is then attached to one or 
both proteins and crystallization by inducing collagen production is then occurred. This 
process is subsequently followed by mineralization collagen matrix (Kubler, et a! .. 
2004), suggesting that osteoblast proliferation and differentiation is highly up-regulated 
by HA (Fig. 1 .3). Increased osteoblast differentiation induced by HA has, indeed, been 
well documented. For example, Hott et al (1997) found that collagen synthesis and 
calcium uptake by human osteoblasts were increased on HA surface. Increased cell 
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proliferation and the production of type I collagen, osteocalcin, osteonectin, 
osteopontin, alkaline phosphate and bone sialoprotein by human osteoblasts on the 
surface of HA, suggesting that human osteoblast proliferation and differentiation to 
form calcified tissue are enhanced by HA (Phan, et al., 2003; Knabe, et al., 2004; 
Ogata, eta/ .. 2005 ;Turhani, eta!., 2005). HA ceramics also induced mesenchymal cell 
differentiaton to osteoblasts (Norman, 1994; Okumura, eta/., 1997; Cong, eta/., 2001). 
It appears to suggest that the ability of HA to induce osteoblast differentiation 
may be \ ia the production of gro\\·th factors such as transforming gro\\·th factor-~ 
(TGF -~) Boyan er ol.. (2003) demonstrated that increased tendency of human 
osteoblast differentiation on HA rough surface is highly associated \Vith increased 
production of this cytokine. Bigi and colleagues also found that the peak production of 
this cytokine HA-stimulated human osteoblast was paralleled with that of type 1 
collagen by these cells (Bigi, et al.. 2005). These previous results have also been 
confirmed by Clarke et ol., (2004) who showed that when HA was incorporated with 
recombinant TGF-~ and then implanted in the proximal tibia of rats, rapid bone 
formation occurred at the implanted site, suggesting that this cy'tokine may accelerate 
osteoblast proliferation and differentiation, and hence, bone formation at the HA 
implanted site. 
1.2.3 Role of Bone-related proteins 
When osteocytes contact with HA surfaces, cell behavior could be altered by the 
surface topography, chemistry and energy (Zreiqat, 1996; Zreiqat, et al., 1999; Zreiqat, 
eta!., 1999; Zreiqat and Howlett, 1999; Zreiqat, et al., 2003; Knabe, et al., 2003). By 
bonding to specific receptors in osteoblast membrane, these extracellular factors start to 
chain reaction inside cells, which eventually result in the alteration in bone-related gene 
and protein expression and the consequence is the changes in osteoblast proliferation 
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and differentiation. Sometimes, these changes in gene expression are favorable for 
osteoblast function (Zreiqat, eta/., 2002). However, these changes may be detrimental 
to osteoblast differentiation and function, which may result in the failure of implant. 
Alkaline phosphatase, osteocalcin, osteonectin, bone sialoprotein and type I collagen are 
some of the most important genes expressed by osteoblasts which can collectively 
contribute to the formation of the osseous matrix and controlled calcification (l'vlundlos, 
1997) 
Different bone matrix proteins haYe different biological functions in bone 
formation. Type I collagen is the major bone matrix protein, which binds to 
hydroxyapatite crystal to pro' ide bone with enough biomechanical strength. Alkaline 
phosphatase, a membrane-bound protein, is the marker of early osteogenesis and it 
functions to proYide free calcium and phosphate for hydroxyapatite crystal growth and 
calcium balance in the body (Owen, eta!., 1990; Strauss, et al., 1990; Gerstenfeld, et 
a! .. 1990; Sodek, eta!, 1991: Pockwmse, eta!, 1992) Osteocalcin is responsible for 
calcium ion binding and is believed to be the marker of late stage of bone formation. 
Experiment results also showed that osteocalcin could doYvn-regulate bone 
mineralization b:y inhibiting the formation of hydroxyapatite crystal in bone (Romberg, 
eta!., 1986) Osteonectin, a multifunctional protein widely expressed in many tissues, is 
a collagen-binding protein and functions as a regulator to the osteoblast proliferation 
(Termine, et a!., 1 981 ). Bone sialoprotein is responsible for the nucleation of HA crystal 
and therefore, it is very important to bone mineralization (Oldberg, et a!., 1988). All 
these bone related genes are highly expressed in the process of osteogenesis in a 
stepwise fashion and they play a crucial role in osteogenesis. 
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1.2.4 Factors Associated With HA-Osteoblast Interaction 
Critical to the long-term success of orthopaedic and dental implants is the 
deYelopment of a stable direct connection between bone and surface implant, which 
must be structural and functional (osteointegration). The establishment and maintenance 
of osteointegration depend on wound healing tissues, repair and remodelling. The tissue 
response to an implant imoh'es physical factors, depending on the implant design, 
surface topography. and chemical factors associated \\ ith the composition <md structure 
of the material. To imprO\ e a direct implant fixation to bone, several strate,sries have 
been developed focusing the attention on the surface of materials. Chemical 
modifications have been realised by covalent attachment of an organic monolayer 
anchored by a siloxane network (Sukenik, et a!., 1990) and immobilising specific 
adhesive peptides, like arginine, glycine, aspartic acid, serine (RGDS) (Dee, et al., 
!996). Surface roughness has been modified by different techniques, because it has been 
demonstrated that the osteoblastic cells tend to attach more rapidly to surfaces with a 
rougher microtopography (Lincks, era!., 1998; Martin, era!., !995) increasing the bone 
apposition (Jiru1o, eta!, 1998; Vercaigne, eta!., 1998). 
Moreover, the implants have been coated with different materials like calcium 
phosphate ceramics, bioactive glass (Matsuda and Davies, 1987; Hayashi, et al., 1989; 
Barth, et a!., 1990; Vrouwenvelder, eta!., 1993; Oliva, et al., 1998; Wheeler, et al., 
1998), diamond-like carbon and amorphous C-N film (Du, eta!., 1998). Many studies 
have been carried out to develop stable hydroxyapatite coatings for their capacity to 
establish a bond vvith tissues in vivo, and to promote rapid attachment and cell growth in 
vitro (De Lange, era!., 1990; Bagambisa, eta!., 1990; Faucheux, et al., 1994). Various 
techniques, such as plasma spray (De Groot, eta/., 1987). Ion beam assisted deposition 
(Cui, et a!., 1997), radiofrequencY, magnetron sputtering (Hulshoff, eta!.. 1995), have 
been used to produce coatings on implants. Some drawbacks have been noticed 
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r regarding the long-term performance of the obtained coatings: coating resorption, poor 
~· 
~" 
mechanical properties, high thickness, non-homogeneity, lack of adherence 
(Kangasniemi, eta!., 1994). 
Substantial amount of work has been done to explore how sintering temperature 
may influence HA ceramic properties and its bioresponses after implantation. Sintering 
temperature can change the crystallinity of HA ceramics and its bioactivity, and thus, 
\vhen sintered at different temperature, they possess different biomechanical strength 
and other physical properties (Ruys, et a/, 1995), osteogenicity (Wang , 1990) and 
initial bonding behavior \Yith bone (Kitsugi, era!., 1987: Kitsugi, eta!., 1988). Sintering 
temperature of HA ceramics can also affect physiological changes in cells, as 
demonstrated by the ionic concentration changes in monocytes in vitro (Laquerriere, et 
a!., 2001 ). When the biological behavior of sintered and unsintered HA were compared, 
totally different properties in protein absorption has been reported. At the molecular 
biology level, different alkaline phosphatase and osteocalcin protein expression were 
reported with different sintering temperatures (Villareal, et al., 1988). When they were 
implanted in vivo, different biological responses were also observed (Wang, 1990). 
Although many studies have explored how sintering temperature may influence the 
osteoblast behavior, little is kno\vn about the molecular levels that determines the 
interaction between the different HA ceramics and their interaction with bone forming 
cells. 
1.3 NITRIC OXIDE 
Nitric oxide (NO) 1s a gaseous molecule generated from L-arginine under 
catalization of nitric oxide synthase (NOS) and produced by cells such as macrophages, 
endothelial cells, and hepatocytes. This free radical gas plays a crucial role on the 
' 
nervous, vascular and immune system (Mayer and Hemmens, 1997). 
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In II.J7'6, it \\as found that nitric oxide (NO) is produced from L-arginine amino 
acid by nitric oxide synthase (NOS), which is present in endothelial cells and other 
tissues (Marietta, 1993). Studies revealed the role of NO in relaxation of smooth 
muscles of arteriole \valls, inhibition of platelet aggregation, and interneuronal 
transaction (Marietta, 1993: Moncada, et a!., 1991 ). Nitric oxide is released from 
macrophages and osteoclasts during cell to cell interactions and acts as a c;1otoxic 
molecule to kill intracellular microorganisms and tumor cells. Nitric oxide also plays a 
role in bone resorption (Henry, eta!., 1991) 
NO is synthesized in mammalian cells by a family of three NO synthases (NOS). 
It is not known whether additional mammalian NOS isoforms exist, but the failure of 
homology based molecular cloning approaches to identify novel NOS cDNAs makes it 
unlikely that newly discovered members of the mammalian NOS gene family \Vill bear 
significant structural similarity to the current trio of isoforms (Michel, era!., 1995). As 
for an) newlv described gene family, an accepted nomenclature of the NOS isoforms 
has evolved only as novel information becomes more generally established. The initial 
NOS nomenclature reflected the early observations that NO synthesis was not 
characteristic of unactivated inflammatory cells, but could become induced upon 
immunoactivation, hence the term iNOS. This prototypic "inducible" iNOS vvas 
contrasted to a "eNOS,, activity that was constitutively expressed in certain 
characteristic cell types (neuronal, endothelial). However, it is now known that the 
levels of gene expression of both eNOS and nNOS may also be induced under different 
physiological conditions (e.g., hemodynamic shear stress or nerve injury), and 
conversely, that iNOS may function as a "constitutive" enzyme under physiological 
conditions in some cells (Guo, eta!., 1995). 
NO is a free radical gas \VJ;lich was discovered to be a physiological mediator in 
1987 after its identification as the moiety responsible for Endothelium-derived 
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relaxation acti Yity (Palmer, et a/., 1987). Since then, NO has emerged as a pleiotropic 
mediator in se\·eral tissues and organ systems (Moncada and Higgs, 1993). Whilst initial 
work focused on the effects of NO on the vascular and nervous systems, an 
accumulating body of evidence has now emerged to suggest that NO plays an important 
role as a paracrine and autocrine mediator of bone cell activity in response to diverse 
stimuli, such as cytokine activation, sex hormone deficiency and mechanical strain. 
1.3.1 Synthesis And Metabolism Of NO 
Nit1ic oxide is generated by the nitric oxide synthase (NOS) group of enzymes 
which combine molecular oxygen \Yith the terminal guanidino nitrogen of the amino 
acid L-arginine to yield NO and L-citrulline as a co-product (Palmer, 1993) (see 
Fig. 1.4) . Under aerobic conditions, NO rapidly reacts with oxygen to yield the stable 
metabolites nitrate (N03) and nitrite (N02). Since the half-life of NO is in the order of 
seconds. direct measurement is difficult, but can be achieved by chemiluminescent 
techniques (Kikuchi, er a!., 1993). More commonly, however, NO production is 
assessed indirectly, by measuring the comersion of radio-labelled L-arginine to L-
citrulline (Bredt and Snyder, 1990), or by measuring accumulation of N03 and N02 in 
biological fluids such as plasma-urine and synovial fluid (Green, eta!., 1982). 
Three isoforms of NOS have been identified that share some homology at the 
nucleotide and amino acid level: a neuronal form (nNOS or NOS I) (Bredt, et al., 1991 ), 
an endothelial form (ecNOS or NOS III) (Robinson, et al., 1994) and an inducible form 
(iNOS or NOS II) (Lowenstein, era!., 1992) (see Fig 1.5). The NOS enzymes, while 
similar in function, differ substantially in terms of regulation\ tissue distribution and 
catalytic activity. Both ecNOS and nNOS are constitutively expressed at low levels in 
their tissues of origin, and for this reason are sometimes collectively referred to as 
'constitutive' NOS (eNOS) enzymes (Marietta, 1993). Since their original discovery, it 
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has become clear that expression of both ecNOS and nNOS is not restricted to 
vasculature and neural tissues; both ha\'e been detected in tumour cell lines (Jenkins, et 
a!., 1994), in gut, muscle, spleen, thymus (Salter, eta!., 1991) and in bone-derived cells 
such as osteoblasts and osteoclasts (Brandi, et a!., 1995; Evans, et a!., 1997) This 
raises the possibility that low leYels ofNO production deriYed from the eNOS enzymes 
may play a more \Yidespread regulatory role than has generally been appreciated. 
]liosynthesis of Nit.rit~ Oxide 
L.-arginine Citrulline 
NO 
Fig. 1.4 Biosynthesis of nitric oxide from L-arginine. Nitric oxide synthases catalyzed 
this reaction. [Figure taken from Bruckdorfer R (2005). Mol Aspect Med 26:3-
31]. 
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Fig. J .5 Structure of nitric oxide synthase (NOS) isoforms. NOS I = ru""lOS; NOS II = 
iN OS: NOS Ill= eNOS. BH.t = tetrahydrobiopterin; Caivl =calmodulin; FAD= 
t1m in adenine dinucleotide; Fl'vlN = flavin mononucleotide: NADPH = nicotine 
adenine dinucleotide phosphate. [Figure taken from Bruckdorfer R (2005). 
Mol Aspect Med 26:3-31 ]. 
The activity of the eNOS enzymes is primarily regulated at a post-translational 
level by changes in free intracellular Ca2 • concentration (iCi-). which binds to 
calmodulin associated with the enzyme to induce a conformational change that increases 
catalytic activity (Marlet1a, 1993). This pathway of NO synthesis is characterized by 
lo\v-output NO production (picomolar concentrations) that can be rapidly modulated by 
external stimuli which alter iCa2+. Relatively little is known of the factors which 
regulate ecNOS and nNOS expression at a transcriptional level. The bovine ecNOS 
gene promoter contains both oestrogen-response elements and shear stress-responsive 
elements (Venema, etal., 1993) suggesting that these stimuli may play a role in 
regulating ecNOS transcription. In keeping with this\ increases in ecNOS mRNA have 
been found in endothelial cells after exposure to physiological concentrations of 
oestrogen (Weiner, et al., 1994; Hayashi, eta!., 1995), and in response to shear stress 
(Uematsu, eta!., 1995). 
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While iNOS also contains a binding site for calmodulin, changes in iCa2+ do not 
substantially alter catalytic acti\ ity because the calcium-calmodulin complex is tightly 
bound to the enzyme under normal physiological conditions. Rather, regulation of iN OS 
principally takes place at the level of gene transcription. The iN OS synthetic pathway is 
acti1·ated by pro- inflammatory C) 1okines such as interleukin-1 (IL-l), tumour necrosis 
factor (TNF). interferon (IFN) gamma and endotoxin in a Yariety of cell types, \\'hereas 
glucocorticoJds and the ~mti-inllammatory cytokines IL--L IL-l 0 and transforming 
growth factor (TGF)-~ are inhibitory (Nathan, 1992; Moncada and Higgs, 1993 ). 
Sequence analysis of the iNOS promoter in rodents and humans has shmYn the presence 
of response elements (RE) which are actiYated by several cytokines, including TNF-RE, 
IFN-RE, NFkB. AP-1, GAS <md NF-IL-6 (Nunokawa, eta!., 199-L Xie, er a/., 1994), 
and molecular studies have shown that transcription driven by the iNOS promoter is 
markedly upregulated by cytokines and endotoxin in minigene constructs linked to 
reporter assays (Xie, era/., 1993: LO\Yenstein, eta/., 1993). Interestingly, studies of the 
human iNOS promoter have shown subst<mtial differences from the murine promoter in 
terms of its inducibility by cytokines. Although the proximal region of the human 
promoter is similar to that of the murine one, the human gene requires much more 5' 
sequence (3,8-16 kb) for cytokine inducibility in vitro (de Vera, et al., 1996), 
suggesting that upstream sequences may be crucial for effective induction by cytokines 
in man. Such differences in genomic organization may partly be responsible for 
differences in the ease with which cytokines can induce NO production in different 
species. For example, the combination of endotoxin and multiple cytokines does not 
effciently activate the iNOS path>vay in human macrophages in vitro (Albina, 1995), 
whereas rodent macrophages can be readily induced to produce large amounts of NO 
upon exposure to only one of these stimuli. Different cell types also differ in their 
ability to produce NO after cytokine stimulation; human primary osteoblast cultures 
21 
require combinations of two or three cytokines for significant induction ofNO (Ralston, 
eta!., 1994 ), \\hereas human chondroc;1es can be induced by single cytokines such as 
IL-l and TNF to produce NO (Hickery, eta!., 1994; Grabowski, et al., 1995). In all cell 
types, however, combinations of cytokines are generally more potent inducers of NO 
than single cytokines (Nussler, et o!, 1992: Ralston, et a! .. 1994; GrabO\Yski, et al., 
1995; Ralston and Grabowski, !l)96) and, irrespectiYe of the primary stimulus, the 
iNOS pathway is thought to be capable of generating much larger quantities of NO 
(nanomolar range) oYer a more prolonged time frame than the eNOS enzymes 
(f\IoncadaandHiggsA. 1993; Palmer, 1993) 
1.3.2 Mechanisms Of NO Action 
Nitric oxide is a reactive molecule and, as such, has many potential molecular 
targets. In vascular smooth muscle and platelets, NO is thought to act by binding to the 
haem moiety or soluble guany·lyl cyclase (sGMP) (Ignarro. eta!, 1986; Ignarro, era!., 
1987) This induces a conformational change vvhich increases enzyme activity, 
resulting in increased production or cyclic GMP. The elevation in cGMP levels causes 
activation of a cascade of cGMP- dependent protein kinases which mediate smooth 
muscle relaxation and inhibition of platelet adhesion. It is of interest that conformational 
changes induced by binding of NO to the haem moiety of the NOS enzymes inhibit 
enzyme activity\ thereby providing an autoregulatory loop by which increased NO 
levels act to limit NO production (Rogers and lgnarro, 1992). 
Other biological effects of NO are mediated by its ability to react with 
sulphydryl residues and iron-sulphur centres in proteins. It is thought that the former 
interaction is responsible for the down- regulation of N-methy-D-aspartate (NMDA) 
receptor activity (Garthwaite, et al., 1988), thus providing a neuroprotective effect, and 
. 
the latter for the inhibitory effect of high NO concentrations on cell growth via the 
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interaction ·with mitochondrial aconitase, a critical enzyme in the Krebs cycle. Protein 
nitrosylation provides a further mechanism of NO action. Nitrotyrosine is readily 
detected in situations characterized by increased production of NO (e.g. in rheumatoid 
synovium) (Blake, eta/., 1996), and the inhibitory effects of NO on DNA synthesis and 
cell division are partly mediated b.Y nitrosylation of a tyros:yl radical at the catalytic site 
of ribonucleotide reductase (Lepoine, eta!., 1992). Since tyrosine is a crucial residue in 
se,·eral signalling molecules, this action of NO could hm e widespread effects on cell 
signaling. Finally, NO can react \\ith oxygen-deri>ed free radicals such as superoxide 
anions to form a cascade of highly reactive species, including the peroxynitrite anion 
cmd the hydroxyl radical (Stamler, et a! .. 1992). Production of such toxic moieties may 
contribute to the tissue damage that is a characteristic feature of an inflammatory 
response by inducing lipid peroxidation and protein nitrosylation (Halliwell and 
Gutteridge, 1990; Lipton, et a!, 1993 ). The interactions of NO with free radicals may 
have consequences for the control of osteoclast function, since superoxide and hydrogen 
peroxide stimulate osteoclastic bone resorption (Garrett eta/.. 1990; Hall, eta!., 1995; 
Fraser, et a!, 1996), and osteoclasts generate superoxide during the process of bone 
resorption (Steinbeck, eta!, 1994). 
1.4 NITRIC OXIDE AND OSTEOBLAST 
1.4.1 Expression Of NOS Isofonns In Bone And Bone-Dedved Cells 
Immunohistochemical studies of whole bone and cultured bone-derived cells 
have shown evidence of widespread ecNOS expression in bone marrow stromal cells, 
osteoblasts, osteocytes and osteoclasts (Brandi, eta!., 1995; Evans, eta!., 1996; Chow, 
et al., 1996), and ecNOS transcripts have been found in freshly isolated bone, 
osteoblasts and bone marrow· cultures by reverse transcription-polymerase chain 
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reaction (RT/PCR) assays. While nNOS mRNA has also been detected in whole bone 
and bone marrow cultures by RT/PCR (Pitsillides, eta!., 1995; Evans, eta!., 1996), this 
isoform has proved more difficult to detect in bone and cultured bone-derived cells by 
immunohisto-chemical techniques. Schmidt, et a!., (1992) failed to detect evidence of 
nNOS in \\hole bone. More recent studies using different antibodies, however, have 
shO\\ n e\ idence of nN OS expression in bone lining cells and osteoc) tes (Chow, et a/., 
1996) . .Although !o\v leYels of iN OS transcripts have been detected in \Vhole bone and 
cultured osteoblasts by RT/PCR, iNOS protein has not been found by immunostaining 
in bone sections or in cultured osteoblasts under basal conditions. The inducible isoform 
has, ho\\ ever, been detected in gro\vth plate chondrocy tes in vivo and in bone marro\v 
macrophages in vitro, even in the absence of cytokine stimulation (Evans, eta!., 1996). 
This may well explain the presence of iN OS transcripts in vvhole bone and the relatively 
high levels of NO production which ha\'e been found under basal. 
Iviost bone cells can be induced to produce iNOS in response to stimulation with 
cytokines and/or endotoxin (Ralston, et a!, 1994; Lowik, eta!.. 1994; Ralston, 1995; 
Ralston and Grabo\vski, 1996; Van't Hof and Ralston, 1997). As in other tissues, 
multiple cytokines have stimulators of NO production in bone cells than single been 
found to be more potent cytokines and rodent cells to be more responsive to cytokines 
than human cells (Damoulis and Hauschka, 1994; MacPherson et a/.,1995). In contrast, 
the calciotropic hormones parathyroid hormone (PTH) and 1 ,25(0H2)D3 do not 
stimulate NO production significantly (Ralston, eta!., 1994; Ralston, eta!., 1995) and, 
in one study, 1 ,25(0H2)D3 was found to inhibit cytokine-induced NO production 
slightly (Lowik, eta/., 1994). It is currently unclear whether osteoclasts are capable of 
producing iNOS. Studies in bone marrow co-cultures show that the majority of 
cytokine-induced NO derives froll} osteoblasts (Van't Hof, 1996), failed to detect iNOS 
protein or mRNA in cultured osteoclasts (Evans, et a!., 1996). Nonetheless, iNOS 
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